• HOME
• ABOUT US
  • Name Address
  • General Description
  • Governance
  • Academic Calendar
  • Degree Programmes
  • List of Programmes in English
  • General Admission and Registration Procedures
  • Credit Mobility and Recognition of Prior Learning
  • ECTS Credit Allocation
  • Academic Guidance
  • Contacts
• Degree Programmes
  • Third Cycle Programmes (Doctorate Degree)
  • Second Cycle Programmes (Master's Degree)
  • First Cycle Programmes (Bachelor's Degree)
  • Short Cycle Programmes (Associate's Degree)
• GENERAL INFORMATION FOR STUDENTS
  • Cost of Living
  • Accommodation
  • Meals
  • Medical Facilities
  • Facilities for Disabled Students
  • Insurance
  • Financial Supports
  • Student Affairs Office
  • Practical Information for International Students
  • Language Courses
  • Work Placement Possibilities
  • Sports, Social and Cultural Facilities
  • Student Associations and Clubs
  • About İzmir - Turkey
• INTERNATIONAL RELATIONS
  • International Relations Office
  • Registration Procedures
  • Agreements
  • Coordinators
  • Documents
  • List of Programmes in English
  • ECTS / DS Labels

Description of Individual Course Units

Course Unit Code Course Unit Title Type Of Course D U L ECTS OKE 5096 SEMINAR COMPULSORY 0 2 0 2

Offered By

CANCER APIDEMIOLOGY

Level of Course Unit

Second Cycle Programmes (Master's Degree)

Course Coordinator

PROFESSOR DOCTOR YASEMIN BAŞBINAR

Offered to

Canser Epidemiology CANCER APIDEMIOLOGY

Course Objective

The aim of this course students who graduate at the program of cancer epidemiology doing literature research to date on current professional issues and gather information, discuss the ability to monitor and evaluate and synthesize the information collected to provide for bringing the framework of ethical values is to provide and discuss

Learning Outcomes of the Course Unit

1   Acquire basic epidemiology, clinical and genetic cancer epidemiology knowledge and ability to practice of the epidemiological techniques. 2   Capable of prepare and present oral and written presentations in the field of cancer epidemiology. 3   Be able to perform works within the framework of the ethical rules in the field of cancer epidemiology. 4   Be able to statistically evaluate the literature studies and criticizes them 5   Capable of uses communication technologies. 6   Be able to participate cancer, epidemiology and research related to national and international meetings, presentations and give speeches at these meetings, the meeting organizer is located teams.

Mode of Delivery

Face -to- Face

Prerequisites and Co-requisites

None

Recomended Optional Programme Components

None

Course Contents

Week Subject Description 1 Seminer-1 2 Seminer-2 3 Seminer-3 4 Seminer-4 5 Seminer-5 6 Seminer-6 7 Seminer-7 8 Seminer-8 9 Seminer-9 10 Seminer-10 11 Seminer-11 12 Seminer-12 13 Seminer-13 14 Seminer-14 15 Seminer-15 16 General assessment

Recomended or Required Reading

pubmed and other literature

Planned Learning Activities and Teaching Methods

Theoretical Lectures, the topics in-class activities (presentations and assignments) to consolidate and discussion and home work.

Assessment Methods

SORTING NUMBER SHORT CODE LONG CODE FORMULA 1 MTE MIDTERM EXAM 2 PRF PERFORMANCE 3 FIN FINAL EXAM 4 FCG FINAL COURSE GRADE MTE * 0.20 +PRF * 0.20 + FIN* 0.60 5 RST RESIT 6 FCGR FINAL COURSE GRADE MTE * 0.20 +PRF * 0.20 +RST* 0.60 *** Resit Exam is Not Administered in Institutions Where Resit is not Applicable.

Further Notes About Assessment Methods

None

Assessment Criteria

1. The learner will clearly define outlined which will evaluate with exam and homework.

Language of Instruction

Turkish

Course Policies and Rules

To be announced.

Contact Details for the Lecturer(s)

To be announced.

Office Hours

To be announced.

Work Placement(s)

None

Workload Calculation

Activities Number Time (hours) Total Work Load (hours) Lectures 16 1 16 Preparation for final exam 1 8 8 Preparing presentations 1 25 25 Final 1 1 1 TOTAL WORKLOAD (hours) 50

Contribution of Learning Outcomes to Programme Outcomes

PO/LO PO.1 PO.2 PO.3 PO.4 PO.5 PO.6 PO.7 PO.8 PO.9 LO.1 5 LO.2 5 LO.3 5 LO.4 5 LO.5 5 LO.6 5